Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 68% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you understand how spread bets, CFDs, OTC options or any of our other products work and whether you can afford to take the high risk of losing your money.

68% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you can afford to take the high risk of losing your money.

A $369bn tailwind for Greencoat, Nordex and Siemens Gamesa shares

As countries ramp up investments in clean energy, wind power stocks like Nordex, Siemens Gamesa Renewable Energy and Greencoat UK Wind stand to gain in the longer term. However, inflation and rising raw material costs could present shorter-term headwinds.   

Clean energy stocks including wind turbine manufacturers such as Nordex [NDX1.DE], Siemens Gamesa Renewable Energy [SGRE.MC] and Greencoat UK Wind [UKW.L] soared after the US’ landmark $369bn climate bill was passed.

The iShares Global Clean Energy ETF [ICLN], First Trust Nasdaq Clean Edge Green Energy Index Fund [QCLN] and Invesco Solar ETF [TAN] were up 15.9%, 16% and 16.9%, respectively, in the two weeks to 10 August.

Wind power is expected to play an important role in the energy transition and has numerous long-term growth drivers. The long-term outlook for wind energy stocks is promising as countries strive to meet net-zero targets.

In 2021, the global offshore wind energy market was worth $9.14bn, according to a report by Research and Markets. It said the market had potential to expand to $24.7bn by 2027, which would reflect a CAGR of 18% over the period of six years.

Nordex lowers 2022 guidance amid restructuring

Founded in 1985 and based in Germany, Nordex is a leading producer and seller of wind turbines. In 2021, the company recorded healthy growth, with sales up 17.1% to €5.4bn, and a 20% rise in installations, which helped its market cap rise by €524m at the end of July.

However, year-to-date, Nordex’s share price has slumped by 23.9% at the close on 10 August. In May, the company adjusted its outlook for 2022, citing the war in Ukraine and restructuring costs as reasons for the lowered guidance. It said the impact of the conflict could reduce sales by €200m and also shifted an operating (EBITDA) margin of -4% to 0% (previously 1% to 3.5%), anticipating “effects from supply chain disruptions coming from China”.

Despite this, analysts remain upbeat about the stock’s future prospects. Last week, Jefferies reaffirmed a ‘buy’ rating for Nordex, with a target price of €16, a considerable upside of 51.2% from its close on 10 August.

Of nine analysts offering a consensus at MarketScreener, three rate it a ‘buy’ and six a ‘hold’. An average 12-month price target of €12.59 would reflect a rise of 18.9% from its most recent close.

 

Can Siemens Gamesa overcome inflationary pressures?

Siemens Gamesa has also encountered challenges in 2022. At the start of August, it lowered its profitability forecast, lowering its 2022 full-year core earnings margin from -4% to -5.5%. It said the rising cost of raw materials, component failures and geopolitical uncertainty were responsible for the pessimistic outlook. The cost of metals, used in turbine blades and masts, have risen considerably since the start of the war in Ukraine.

Year-to-date, the Siemens Gamesa share price has slipped by 14.6% as of 10 August, a smaller fall than Nordex, but still significant. 

At CNN, 14 analysts offering 12-month price forecasts for the US-listed Siemens Gamesa [GCTAY] stock have a median target of $3.68, which is only 1.93% above its $3.61 close on 8 August. Twelve out of 15 analysts currently rate it a ‘hold’, suggesting the jury is out on how well Siemens Gamesa stock will perform in future.

Greencoat UK Wind sees strong revenue growth

Greencoat has proven to be a robust business. Net asset value for the first six months of 2022 was £3.6m, compared to £3.1m during the last half of 2021. The company’s operating portfolio also increased from £3.9m to £4.2m in the first six months of the year.

At its half-year results, Shonaid Jemmett-Page, the chair of Greencoat UK Wind, praised “another solid performance”, reporting that the company had acquired Twentyshillling wind farm and was investing in Hornsea 1, “the world's largest offshore wind farm”, which will be located 120km off the Yorkshire coast.

Greencoat’s share price is up 20% year-to-date, closing at 162.67p on 10 August, outperforming Nordex and Siemens Gamesa. Over the past 12 months, Greencoat’s share price has grown by 26.8%.

A consensus of five analysts at MarketScreener deem the stock a firm ‘buy’. They offer a target of 200p, which would represent a rise of 22.3% from its last close.

Disclaimer Past performance is not a reliable indicator of future results.

CMC Markets is an execution-only service provider. The material (whether or not it states any opinions) is for general information purposes only, and does not take into account your personal circumstances or objectives. Nothing in this material is (or should be considered to be) financial, investment or other advice on which reliance should be placed. No opinion given in the material constitutes a recommendation by CMC Markets or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person.

The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although we are not specifically prevented from dealing before providing this material, we do not seek to take advantage of the material prior to its dissemination.

CMC Markets does not endorse or offer opinion on the trading strategies used by the author. Their trading strategies do not guarantee any return and CMC Markets shall not be held responsible for any loss that you may incur, either directly or indirectly, arising from any investment based on any information contained herein.

*Tax treatment depends on individual circumstances and can change or may differ in a jurisdiction other than the UK.

Continue reading for FREE

Latest articles